Document
true0001376339 0001376339 2020-08-31 2020-08-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________

FORM 8-K/A
____________________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 31, 2020
MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
Florida
 
001-35887
 
26-2792552
(State or other jurisdiction
 
(Commission
 
(IRS Employer
of incorporation)
 
File Number)
 
Identification No.)

1775 West Oak Commons Ct., NE, Marietta GA 30062
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (770) 651-9100
____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange
on which registered
None
 
n/a
 
n/a

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐















Item 5.07
Submission of Matters to a Vote of Security Holders.

Say on Frequency Determination

(d) On August 31, 2020, MiMedx Group, Inc. (the "Company") held its 2019 Annual Meeting.

At the 2019 Annual Meeting, among other things, shareholders approved a resolution that the Company's advisory vote on the Company's executive compensation be conducted annually.

On September 29, 2020, in light of such shareholder advisory vote, the Company's Board of Directors has determined to implement an annual say-on-pay vote beginning with the 2021 annual meeting of shareholders.
 

SIGNATURES

Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
MIMEDX GROUP, INC.
 
 
 
Date: October 5, 2020
By:
/s/ Peter M. Carlson
 
 
Peter M. Carlson
Chief Financial Officer